BAJAJ BROKING

Notification
No new Notification messages
Divine Hira Jewellers IPO is Open!
Apply for the Divine Hira Jewellers IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
apollo hospitals enter. l stock

APOLLO HOSPITALS ENTER. L Share Price

6246.8 90.14 (1.46%)
Mar 18 2025 03:30 PM Healthcare NSE: APOLLOHOSP

APOLLO HOSPITALS ENTER. L Share Price Update

As of the latest trading session, APOLLO HOSPITALS ENTER. L share price is currently at 6246.8, which is up by 90.14 from its previous closing. Today, the stock has fluctuated between 6162.50 and 6260.95. Over the past year, APOLLO HOSPITALS ENTER. L has achieved a return of 0.32 %. In the last month alone, the return has been -2.27 %. Read More...

APOLLO HOSPITALS ENTER. L Performance

Day Range

Low6162.50 High6260.95
6246.80

52 Week Range

Low 5693.20 High 7545.35
6246.80

APOLLO HOSPITALS ENTER. L Share Price

157

508869

APOLLOHOSP

img img img img
No Data Available

Open Price

6209.90

Prev. Close

6156.65

Volume (Shares)

308477.00

Total traded value

19269.94

Upper Circuit

6772.30

Lower Circuit

5541.00

Note: The current prices & values are delayed, Login to your account for live updates.

APOLLO HOSPITALS ENTER. L Fundamentals


(Standalone)

Market Cap (Cr) 89819.40
PE Ratio (TTM) 73.63
Book Value / Share 569.62
Beta 0.54
ROE 13.81%
EPS (TTM) 83.58
Dividend Yield 0.26%
Net Profit Qtr (Cr) 341.60

APOLLO HOSPITALS ENTER. L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 2054.80
Operating Expense 1713.40
Net Profit 341.60
Net Profit Margin (%) 16.62
Earnings Per Share (EPS) 23.76
EBITDA 619.70
Effective Tax Rate (%) 23.97
Particulars SEP 2024 (Values in Cr)
Revenue 2135.40
Operating Expense 1768.80
Net Profit 369.60
Net Profit Margin (%) 17.30
Earnings Per Share (EPS) 25.71
EBITDA 661.19
Effective Tax Rate (%) 24.18
Particulars JUN 2024 (Values in Cr)
Revenue 1936.60
Operating Expense 1632.20
Net Profit 251.70
Net Profit Margin (%) 12.99
Earnings Per Share (EPS) 17.51
EBITDA 498.10
Effective Tax Rate (%) 24.11
Particulars MAR 2024 (Values in Cr)
Revenue 1894.60
Operating Expense 1628.20
Net Profit 238.80
Net Profit Margin (%) 12.60
Earnings Per Share (EPS) 16.61
EBITDA 496.40
Effective Tax Rate (%) 23.55
Particulars DEC 2023 (Values in Cr)
Revenue 1824.30
Operating Expense 1531.80
Net Profit 262.80
Net Profit Margin (%) 14.40
Earnings Per Share (EPS) 18.28
EBITDA 501.80
Effective Tax Rate (%) 23.60
Particulars MAR 2024 (Values in Cr)
Revenue 7273.80
Operating Expense 6125.10
Net Profit 1010.50
Net Profit Margin (%) 13.89
Earnings Per Share (EPS) 70.28
EBITDA 1977.39
Effective Tax Rate (%) 23.94
Particulars MAR 2023 (Values in Cr)
Revenue 6524.80
Operating Expense 5448.80
Net Profit 1084.80
Net Profit Margin (%) 16.62
Earnings Per Share (EPS) 75.45
EBITDA 1833.00
Effective Tax Rate (%) 11.62
Particulars MAR 2022 (Values in Cr)
Revenue 6098.33
Operating Expense 5286.45
Net Profit 665.03
Net Profit Margin (%) 10.90
Earnings Per Share (EPS) 46.25
EBITDA 1459.59
Effective Tax Rate (%) 32.83
Particulars MAR 2021 (Values in Cr)
Revenue 4653.86
Operating Expense 4702.30
Net Profit 105.16
Net Profit Margin (%) 2.25
Earnings Per Share (EPS) 16.90
EBITDA 720.78
Effective Tax Rate (%) 35.21
Particulars MAR 2020 (Values in Cr)
Revenue 9794.43
Operating Expense 9287.33
Net Profit 470.25
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 33.80
EBITDA 1590.50
Effective Tax Rate (%) 31.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 481.75
ROE % 13.98
ROCE % 15.37
Total Debt to Total Equity 0.74
EBITDA Margin 13.11
Particulars MAR 2023 (Values in Cr)
Book Value / Share 430.43
ROE % 15.04
ROCE % 14.16
Total Debt to Total Equity 0.71
EBITDA Margin 12.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 390.51
ROE % 17.26
ROCE % 16.67
Total Debt to Total Equity 0.81
EBITDA Margin 15.29
Particulars MAR 2021 (Values in Cr)
Book Value / Share 319.52
ROE % 2.41
ROCE % 6.47
Total Debt to Total Equity 0.98
EBITDA Margin 11.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 239.32
ROE % 9.20
ROCE % 11.88
Total Debt to Total Equity 1.09
EBITDA Margin 14.38
Particulars MAR 2024 (Values in Cr)
Book Value / Share 536.22
ROE % 13.81
ROCE % 15.48
Total Debt to Total Equity 0.39
EBITDA Margin 27.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 481.56
ROE % 16.64
ROCE % 16.00
Total Debt to Total Equity 0.40
EBITDA Margin 28.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 424.94
ROE % 11.56
ROCE % 12.62
Total Debt to Total Equity 0.51
EBITDA Margin 23.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 361.72
ROE % 2.29
ROCE % 5.12
Total Debt to Total Equity 0.68
EBITDA Margin 18.31
Particulars MAR 2020 (Values in Cr)
Book Value / Share 286.52
ROE % 9.10
ROCE % 12.05
Total Debt to Total Equity 0.81
EBITDA Margin 14.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 933.80
Total Assets 16753.10
Total Liabilities 16753.10
Total Equity 7320.50
Share Outstanding 143784657
Price to Book Ratio 11.85
Return on Assets (%) 5.36
Return on Capital (%) 8.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 775.80
Total Assets 14427.80
Total Liabilities 14427.80
Total Equity 6531.30
Share Outstanding 143784657
Price to Book Ratio 8.95
Return on Assets (%) 5.67
Return on Capital (%) 8.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 924.00
Total Assets 13269.30
Total Liabilities 13269.30
Total Equity 5903.00
Share Outstanding 143784657
Price to Book Ratio 10.63
Return on Assets (%) 7.95
Return on Capital (%) 12.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 724.40
Total Assets 11416.70
Total Liabilities 11416.70
Total Equity 4802.40
Share Outstanding 143784657
Price to Book Ratio 8.03
Return on Assets (%) 1.31
Return on Capital (%) 1.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 466.80
Total Assets 11338.40
Total Liabilities 11338.40
Total Equity 3469.80
Share Outstanding 139125160
Price to Book Ratio 3.97
Return on Assets (%) 4.01
Return on Capital (%) 6.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 342.20
Total Assets 12405.20
Total Liabilities 12405.20
Total Equity 7710.90
Share Outstanding 143784657
Price to Book Ratio 11.85
Return on Assets (%) 8.14
Return on Capital (%) 10.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 318.00
Total Assets 10780.40
Total Liabilities 10780.40
Total Equity 6924.80
Share Outstanding 143784657
Price to Book Ratio 8.95
Return on Assets (%) 10.06
Return on Capital (%) 12.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 556.90
Total Assets 10408.20
Total Liabilities 10408.20
Total Equity 6110.70
Share Outstanding 143784657
Price to Book Ratio 10.63
Return on Assets (%) 6.39
Return on Capital (%) 8.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 408.20
Total Assets 9729.20
Total Liabilities 9729.20
Total Equity 5201.50
Share Outstanding 143784657
Price to Book Ratio 8.03
Return on Assets (%) 1.07
Return on Capital (%) 1.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 346.50
Total Assets 10144.20
Total Liabilities 10144.20
Total Equity 3988.40
Share Outstanding 139125160
Price to Book Ratio 3.97
Return on Assets (%) 4.63
Return on Capital (%) 6.77
Particulars MAR 2024 (Values in Cr)
Net Income 935.00
Cash from Operations 2386.90
Cash from Investing -1537.20
Cash from Financing -311.00
Net change in Cash 72.00
Free Cash Flow 3523.70
Particulars MAR 2023 (Values in Cr)
Net Income 844.30
Cash from Operations 1758.90
Cash from Investing -870.60
Cash from Financing -633.20
Net change in Cash -126.90
Free Cash Flow 2887.40
Particulars MAR 2022 (Values in Cr)
Net Income 1108.40
Cash from Operations 1900.30
Cash from Investing -847.20
Cash from Financing -791.60
Net change in Cash 57.20
Free Cash Flow 2557.50
Particulars MAR 2021 (Values in Cr)
Net Income 136.80
Cash from Operations 1229.30
Cash from Investing -863.40
Cash from Financing -340.10
Net change in Cash 61.10
Free Cash Flow 1524.80
Particulars MAR 2020 (Values in Cr)
Net Income 431.70
Cash from Operations 1598.90
Cash from Investing -288.80
Cash from Financing -909.60
Net change in Cash 94.50
Free Cash Flow 2111.90
Particulars MAR 2024 (Values in Cr)
Net Income 1010.50
Cash from Operations 1521.40
Cash from Investing -835.30
Cash from Financing -297.00
Net change in Cash 59.10
Free Cash Flow 2142.40
Particulars MAR 2023 (Values in Cr)
Net Income 1084.80
Cash from Operations 1547.90
Cash from Investing -588.50
Cash from Financing -778.60
Net change in Cash -142.60
Free Cash Flow 1943.90
Particulars MAR 2022 (Values in Cr)
Net Income 665.20
Cash from Operations 1299.40
Cash from Investing -505.30
Cash from Financing -576.60
Net change in Cash 119.00
Free Cash Flow 1823.00
Particulars MAR 2021 (Values in Cr)
Net Income 105.00
Cash from Operations 911.70
Cash from Investing -764.70
Cash from Financing -175.60
Net change in Cash -24.80
Free Cash Flow 1105.90
Particulars MAR 2020 (Values in Cr)
Net Income 470.30
Cash from Operations 1347.00
Cash from Investing -263.90
Cash from Financing -770.70
Net change in Cash 61.50
Free Cash Flow 1784.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
FORTIS MALAR HOSPITALS LIMITED 64.58 157.51 4.05 121.03 44.00 / 107.94
SHREE PACETRONIX LTD. 67.33 14.03 1.80 24.23 66.25 / 268.50
TRANSGENE BIOTEK LTD. 3.84 0.00 2.68 29.10 3.54 / 10.84
VIMTA LABS LIMITED 1022.85 37.40 6.63 2273.06 420.00 / 1183.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 30.40 0.00 -16.28 22.71 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5330.40 28.25 5.98 5831.46 3553.10 / 6400.00
FORTIS MALAR HOSPITALS LIMITED 64.58 46.46 4.09 121.03 44.00 / 107.94

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 6149.40
  • 26 Days 6323.80
  • 10 Days 6176.60
  • 50 Days 6515.10
  • 12 Days 6191.50
  • 100 Days 6678.70
  • 20 Days 6265.30
  • 200 Days 6610.60
6129.25
PIVOT
First Resistance 6176.40
Second Resistance 6247.15
Third Resistance 6294.30
First Support 6058.50
Second Support 6011.35
Third Support 5940.60
RSI 38.20
MACD -132.26
Commodity Channel Index (CCI) -82.75
ADX 43.17
Williams % R -50.39

Over 1 Month

down

-2.27

Over 3 Months

down

-14.71

Over 6 Months

down

-12.14

Over 1 Year

down

0.32

Over 3 Years

down

8.35

Over 5 Years

down

33.96

APOLLO HOSPITALS ENTER. L Future

Future: Price

27 Mar
6254.10
24 Apr
6289.00
29 May
6307.60
25 May
0 100 200 300 400 500 600

Discount/Premium

27 Mar
7.30
24 Apr
42.20
29 May
60.80
25 May
0 1 2 3 4 5 6 7

Active Calls

6300.0
4945
6200.0
2913
6250.0
1866
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

6200.0
2070
6100.0
1595
6000.0
1476
25 Jul
0 500 1000 1500 2000 2500

APOLLO HOSPITALS ENTER. L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
5.41
Promoter Holdings
29.33
FII
45.26
DII
19.97
Promoter Shares(Pledge Percentage)
13.47
Name Category Shares Shares%
M/s. Pcr Investments Ltd Shareholding of Promoter and Promoter Group 2.7223124E7 18.93
Life Insurance Corporation Of India Public Shareholding 5383226.0 3.74
Ms. Suneeta Reddy Shareholding of Promoter and Promoter Group 4834305.0 3.36
Hdfc Trustee Company Limited Public Shareholding 3633203.0 2.53
Ms. Sangita Reddy Shareholding of Promoter and Promoter Group 2432508.0 1.69
Government Of Singapore Public Shareholding 2360690.0 1.64
Ms. Shobana Kamineni Shareholding of Promoter and Promoter Group 2239952.0 1.56
Sbi Nifty 50 Etf Public Shareholding 2105090.0 1.46
Schroder International Selection Fund Asian Opportunities Public Shareholding 1842343.0 1.28
Government Pension Fund Global Public Shareholding 1630465.0 1.13
Axis Focused Fund Account Public Shareholding 1622563.0 1.13
Mr. K Vishweshwar Reddy Shareholding of Promoter and Promoter Group 1577350.0 1.1
Nps Trust Public Shareholding 1588367.0 1.1
Kotak Funds - India Midcap Fund Public Shareholding 1540000.0 1.07
Mirae Asset Elss Tax Saver Fund Public Shareholding 1511245.0 1.05
Ms. Preetha Reddy Shareholding of Promoter and Promoter Group 1043915.0 0.73
Mr. Karthik Anand Shareholding of Promoter and Promoter Group 345238.0 0.24
Mr. Harshad Reddy Shareholding of Promoter and Promoter Group 327900.0 0.23
Ms. Sindoori Reddy Shareholding of Promoter and Promoter Group 318600.0 0.22
Ms. Anuspala Kamineni Shareholding of Promoter and Promoter Group 259174.0 0.18
Dr. Prathap C Reddy Shareholding of Promoter and Promoter Group 245464.0 0.17
Mr. Konda Anindith Reddy Shareholding of Promoter and Promoter Group 230200.0 0.16
Mr. Puansh Kamineni Shareholding of Promoter and Promoter Group 212201.0 0.15
Ms. Upasana Konidela Shareholding of Promoter and Promoter Group 217276.0 0.15
Mr. Konda Vishwajit Reddy Shareholding of Promoter and Promoter Group 222300.0 0.15
Ms. Sucharitha P Reddy Shareholding of Promoter and Promoter Group 169800.0 0.12
Mr. Konda Viraj Madhav Reddy Shareholding of Promoter and Promoter Group 168224.0 0.12
M/s. Indian Hospitals Corporation Ltd Shareholding of Promoter and Promoter Group 61704.0 0.04
Mr. Dwaraknath Reddy Shareholding of Promoter and Promoter Group 18000.0 0.01
Mr. Vijay Kumar Reddy Shareholding of Promoter and Promoter Group 8957.0 0.01
Mr. Aditya Reddy Shareholding of Promoter and Promoter Group 10200.0 0.01
M/s. Obul Reddy Investments Pvt Ltd Shareholding of Promoter and Promoter Group 11200.0 0.01
Mr. Anil Kamineni Shareholding of Promoter and Promoter Group 20.0 0.0

APOLLO HOSPITALS ENTER. L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-20 6.0 Interim 2024-02-20 Equity shares 2023-08-18 9.0 Final 2023-08-19 Equity shares 2023-02-24 6.0 Interim 2023-02-24 Equity shares 2022-08-18 11.75 Final 2022-08-20 Equity shares 2021-08-18 3.0 Final 2021-08-21 Equity shares 2020-09-17 2.75 Final 2020-09-19 Equity shares 2020-02-25 3.25 Interim 2020-02-26 Equity shares 2019-09-12 6.0 Final 2019-09-14 Equity shares 2018-09-12 5.0 Final 2018-09-15 Equity shares 2017-09-07 6.0 Final 2017-09-09 Equity shares 2016-03-22 6.0 Interim 2016-03-23 Equity shares 2015-07-30 5.75 Final 2015-08-01 Equity shares 2014-08-13 5.75 Final 2014-08-19 Equity shares 2013-07-25 5.5 Final 2013-07-27 Equity shares 2012-07-26 4.0 Final 2012-07-28 Equity shares 2011-07-07 3.75 Final 2011-07-09 Equity shares 2010-07-15 7.0 Final 2010-07-17 Equity shares 2009-08-20 6.5 Final 2009-08-22 Equity shares 2008-08-11 6.0 Final 2008-08-13 Equity shares 2007-08-09 2.0 Final 2007-08-11 Equity shares 2007-03-22 3.0 Interim 2007-03-24 Equity shares 2005-07-29 0.0 Final 2005-08-02 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2010-09-02 10.0 5.0 2010-09-03

Apollo Hospitals Enterprise Limited Overview

Apollo Hospitals, founded in 1983 by Dr. Prathap C Reddy, marked the advent of the corporate hospital model in India, leading the private healthcare revolution. It has since established itself as Asia’s leading integrated healthcare services provider, with an extensive presence across the healthcare spectrum, including hospitals, pharmacies, primary care, diagnostic clinics, and various retail health models. As of Q1FY24, Apollo boasts 43 owned and 6 managed hospitals across major urban centres, including Chennai and Hyderabad, offering over 9,500 beds, achieving an occupancy rate of 62%, and an average revenue per occupied bed (ARPOB) of Rs. 57,760. The diagnostics and retail health segment further includes 22 ambulatory care & birthing centres, over 2,000 diagnostics centres, and more than 120 dialysis centres. The digital health and pharmacy distribution network encompasses over 5,600 outlets, with significant growth in the last fiscal year, contributing to a 41% share of the company’s revenue. Notably, Apollo has achieved global recognition in solid multi-organ transplantation, leading with over 23,000 transplants and expanding its robotic colorectal surgery program. The revenue distribution reflects a significant emphasis on healthcare services, contributing 52%, with diagnostics and retail health and digital health & pharma rounding out the financial ecosystem. This comprehensive approach underlines Apollo Hospitals' commitment to innovating and expanding its services, reinforcing its position as a healthcare leader in India and beyond.

Apollo Hospitals Share Result Highlights  

Apollo Hospitals Enterprise Ltd. is an Indian healthcare provider and also happens to be the first corporate hospital in India. The company is a huge player in the healthcare industry and provides various services like medical care, diagnostics, and pharmacy services. As of 21 January 2025, 04:01 pm, Apollo Hospitals share price stood at  ₹6919.15 per share.

Apollo Hospitals Share Annual Reports 

According to their Annual Report 2023-24, Apollo Hospital’s operating income fell by 0.2% YoY while its operating profit grew by 55.7% YoY. The net profit of the company also saw a growth of 61.6% YoY and its net profit margins grew from 13.9% in FY23 to 22.5% in FY24.

Apollo Hospitals Share Dividend          

The company announced its last dividend in the quarter ending March 2024. The dividend declared stood at ₹10 which translates to a dividend yield of 0.36%.

About APOLLO HOSPITALS ENTER. L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by APOLLO HOSPITALS ENTER. L

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Apollo Hospitals Enterprise Ltd?

Answer Field

The share price of Apollo Hospitals Enterprise Ltd for NSE is ₹ 6246.8 and for BSE is ₹ 6255.05.

What is the Market Cap of Apollo Hospitals Enterprise Ltd?

Answer Field

The market cap of Apollo Hospitals Enterprise Ltd for NSE is ₹ 8,98,19.40 Cr. and for BSE is ₹ 8,99,38.02 Cr. as of now.

What is the 52 Week High and Low of Apollo Hospitals Enterprise Ltd?

Answer Field

The 52 Week High and Low of Apollo Hospitals Enterprise Ltd for NSE is ₹ 7545.35 and ₹ 5693.20 and for BSE is ₹ 7545.10 and ₹ 5690.80.

How to Buy Apollo Hospitals Enterprise Ltd share?

Answer Field

You can trade in Apollo Hospitals Enterprise Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Apollo Hospitals Enterprise Ltd?

Answer Field

The 1 year returns on the stock has been 0.32%.

What is the Current Share Price of Apollo Hospitals Enterprise Ltd?

Answer Field

Apollo Hospitals Enterprise Ltd share price is for NSE ₹ 6246.8 & for BSE ₹ 6255.05 as on Mar 18 2025 03:30 PM.

What is the Market Cap of Apollo Hospitals Enterprise Ltd Share?

Answer Field

The market cap of Apollo Hospitals Enterprise Ltd for NSE ₹ 8,98,19.40 & for BSE ₹ 8,99,38.02 as on Mar 18 2025 03:30 PM.

What is the P/E Ratio of Apollo Hospitals Enterprise Ltd Share?

Answer Field

As on Mar 18 2025 03:30 PM the price-to-earnings (PE) ratio for Apollo Hospitals Enterprise Ltd share is 73.63.

What is the PB ratio of Apollo Hospitals Enterprise Ltd Share?

Answer Field

As on Mar 18 2025 03:30 PM, the price-to-book (PB) ratio for Apollo Hospitals Enterprise Ltd share is 569.62.

How to Buy Apollo Hospitals Enterprise Ltd Share?

Answer Field

You can trade in Apollo Hospitals Enterprise Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Apollo Hospitals Enterprise Ltd Share on Bajaj Broking App?

Answer Field

To buy Apollo Hospitals Enterprise Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Apollo Hospitals Enterprise Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs

  1. Who is the CEO of Apollo Hospitals Enterprise Ltd?

    The CEO of Apollo Hospitals Enterprise Ltd is Dr Madhu Sasidhar.

  2. When was Apollo Hospitals Enterprise Ltd established?

    The company was established on 18 September 1983.

  3. What factors influence the Apollo Hospitals Share Price?

    Factors like the company’s expansion strategy, profit and revenue growth, and international patients have a great impact on the Apollo Hospitals Share Price.

  4. Is Apollo Hospitals Enterprise Ltd debt-free?

    No, the company is not debt-free.

  5. What is the CAGR of Apollo Hospitals Share?

    The company's CAGR for the past 5 years stands between 26.3% and 63.8%.

  6. How has the Apollo Hospitals Share Price performed over the past year?

    Apollo Hospital’s operating income fell by 0.2% YoY, while its operating profit grew by 55.7% YoY. The net profit of the company also saw a growth of 61.6% YoY, and its net profit margins grew from 13.9% in FY23 to 22.5% in FY24.

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
loader